Europe Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Stability Testing, Method Development & Validation), By End-use (Pharmaceutical Companies), By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Market Size & Trends
The Europe pharmaceutical analytical testing services in CRO market size was estimated at USD 2.3 billion in 2024 and is projected tgrow at a CAGR of 8.34% from 2025 t2030. The increasing demand for outsourcing analytical testing services among pharmaceutical companies, driven by stringent regulatory requirements and the need for cost-effective solutions, is a key factor contributing tmarket growth. Advancements in analytical testing are improving accuracy and efficiency, further supporting the market's expansion.
The industry has been advancing at a rapid pace due tan increasing demand for the analytical testing of biologics and biosimilars. The increasing incidence rate of chronic disorders such as inflammatory bowel diseases, cancer, and rheumatoid arthritis has emphasized the need for biologics.
The presence of advanced bioanalytical testing service facilities in Europe has led tnoticeable improvements in areas such as drug development & clinical research, driving market expansion. These services comprise a vital aspect of the analysis of pharmaceutical compounds, such as biologics and small molecules, with leading providers offering methods such as immunoassays, chromatography, and biomarker analysis.
Technological advancements are improving the precision, efficiency, and cost-effectiveness of analytical testing services. Enhanced methodologies allow for comprehensive quality assessments, ensuring drug safety and efficacy throughout the development lifecycle. Growing investments in research and development, along with strategic collaborations between pharmaceutical companies and CROs, are expected tfurther drive market growth. With an increasing focus on regulatory compliance and streamlined drug development processes, the demand for analytical testing services is anticipated trise steadily.
Europe Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t2030. For this study, Grand View Research has segmented the Europe pharmaceutical analytical testing services in CRO market report based on service, end use, and country:
Market Size & Trends
The Europe pharmaceutical analytical testing services in CRO market size was estimated at USD 2.3 billion in 2024 and is projected tgrow at a CAGR of 8.34% from 2025 t2030. The increasing demand for outsourcing analytical testing services among pharmaceutical companies, driven by stringent regulatory requirements and the need for cost-effective solutions, is a key factor contributing tmarket growth. Advancements in analytical testing are improving accuracy and efficiency, further supporting the market's expansion.
The industry has been advancing at a rapid pace due tan increasing demand for the analytical testing of biologics and biosimilars. The increasing incidence rate of chronic disorders such as inflammatory bowel diseases, cancer, and rheumatoid arthritis has emphasized the need for biologics.
The presence of advanced bioanalytical testing service facilities in Europe has led tnoticeable improvements in areas such as drug development & clinical research, driving market expansion. These services comprise a vital aspect of the analysis of pharmaceutical compounds, such as biologics and small molecules, with leading providers offering methods such as immunoassays, chromatography, and biomarker analysis.
Technological advancements are improving the precision, efficiency, and cost-effectiveness of analytical testing services. Enhanced methodologies allow for comprehensive quality assessments, ensuring drug safety and efficacy throughout the development lifecycle. Growing investments in research and development, along with strategic collaborations between pharmaceutical companies and CROs, are expected tfurther drive market growth. With an increasing focus on regulatory compliance and streamlined drug development processes, the demand for analytical testing services is anticipated trise steadily.
Europe Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t2030. For this study, Grand View Research has segmented the Europe pharmaceutical analytical testing services in CRO market report based on service, end use, and country:
- Service Outlook (Revenue, USD Million, 2018 - 2030)
- Bioanalytical Testing
- Clinical
- Non- Clinical
- Method Development and Validation
- Extractable and Leachable
- Impurity Method
- Technical Consulting
- Other Method Validation Services
- Stability Testing
- Drug Substance
- Stability Indicating Method Validation
- Accelerated Stability Testing
- Photostability Testing
- Other Stability Testing Services
- Other Testing Services
- End Use (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Poland
- Switzerland
- Austria
- Czech Republic
- Croatia
- Slovenia
- Greece
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: SERVICE BUSINESS ANALYSIS
4.1. Service Market Share, 2024 & 2030
4.2. Service Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market, 2018 - 2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market, 2018 - 2030 (USD Million)
4.4.3. Non- Clinical
4.4.3.1. Non- Clinical Market, 2018 - 2030 (USD Million)
4.5. Method Development and Validation
4.5.1. Method Development and Validation Market, 2018 - 2030 (USD Million)
4.5.2. Extractable and Leachable
4.5.2.1. Extractable and Leachable Market, 2018 - 2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market, 2018 - 2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market, 2018 - 2030 (USD Million)
4.5.5. Other Method Validation Services
4.5.5.1. Other Method Validation Services Market, 2018 - 2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market, 2018 - 2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market, 2018 - 2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market, 2018 - 2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market, 2018 - 2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market, 2018 - 2030 (USD Million)
4.6.6. Other Stability Testing Services
4.6.6.1. Other Stability Testing Services Market, 2018 - 2030 (USD Million)
4.7. Other Testing Services
4.7.1. Other Testing Services Market, 2018 - 2030 (USD Million)
CHAPTER 5. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: END USE BUSINESS ANALYSIS
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 6. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. Europe
6.4.1. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. France Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Regulatory Framework
6.4.5.3. Competitive Insights
6.4.5.4. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Regulatory Framework
6.4.6.3. Competitive Insights
6.4.6.4. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.7. Norway
6.4.7.1. Key Country Dynamics
6.4.7.2. Regulatory Framework
6.4.7.3. Competitive Insights
6.4.7.4. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Regulatory Framework
6.4.8.3. Competitive Insights
6.4.8.4. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.9. Sweden
6.4.9.1. Key Country Dynamics
6.4.9.2. Regulatory Framework
6.4.9.3. Competitive Insights
6.4.9.4. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Regulatory Framework
6.4.10.3. Competitive Insights
6.4.10.4. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Regulatory Framework
6.4.11.3. Competitive Insights
6.4.11.4. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Regulatory Framework
6.4.12.3. Competitive Insights
6.4.12.4. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Regulatory Framework
6.4.13.3. Competitive Insights
6.4.13.4. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Regulatory Framework
6.4.14.3. Competitive Insights
6.4.14.4. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Regulatory Framework
6.4.15.3. Competitive Insights
6.4.15.4. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Regulatory Framework
6.4.16.3. Competitive Insights
6.4.16.4. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. SGS Sociйtй Gйnйrale de Surveillance SA
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Worldwide Clinical Trials
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Sofpromed
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. ClinChoice
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Evotec
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Eurofins Scientific
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. KYMOS Group
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. ViviaBiotech S.L.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. GalChimia
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. TCI Laboratories
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. Cotecna (NEOTRON SpA,)
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. Tentamus
7.5.12.1. Company Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. Enzymlogic
7.5.13.1. Company Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
7.5.14. Pharmbiotest
7.5.14.1. Company Overview
7.5.14.2. Financial Performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic Initiatives
7.5.15. UNIFARM - Research Centre
7.5.15.1. Company Overview
7.5.15.2. Financial Performance
7.5.15.3. Product Benchmarking
7.5.15.4. Strategic Initiatives
7.5.16. ANAPHARM EUROPE, S.L.U
7.5.16.1. Company Overview
7.5.16.2. Financial Performance
7.5.16.3. Product Benchmarking
7.5.16.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: SERVICE BUSINESS ANALYSIS
4.1. Service Market Share, 2024 & 2030
4.2. Service Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
4.4. Bioanalytical Testing
4.4.1. Bioanalytical Testing Market, 2018 - 2030 (USD Million)
4.4.2. Clinical
4.4.2.1. Clinical Market, 2018 - 2030 (USD Million)
4.4.3. Non- Clinical
4.4.3.1. Non- Clinical Market, 2018 - 2030 (USD Million)
4.5. Method Development and Validation
4.5.1. Method Development and Validation Market, 2018 - 2030 (USD Million)
4.5.2. Extractable and Leachable
4.5.2.1. Extractable and Leachable Market, 2018 - 2030 (USD Million)
4.5.3. Impurity Method
4.5.3.1. Impurity Method Market, 2018 - 2030 (USD Million)
4.5.4. Technical Consulting
4.5.4.1. Technical Consulting Market, 2018 - 2030 (USD Million)
4.5.5. Other Method Validation Services
4.5.5.1. Other Method Validation Services Market, 2018 - 2030 (USD Million)
4.6. Stability Testing
4.6.1. Stability Testing Market, 2018 - 2030 (USD Million)
4.6.2. Drug Substance
4.6.2.1. Drug Substance Market, 2018 - 2030 (USD Million)
4.6.3. Stability Indicating Method Validation
4.6.3.1. Stability Indicating Method Validation Market, 2018 - 2030 (USD Million)
4.6.4. Accelerated Stability Testing
4.6.4.1. Accelerated Stability Testing Market, 2018 - 2030 (USD Million)
4.6.5. Photostability Testing
4.6.5.1. Photostability Testing Market, 2018 - 2030 (USD Million)
4.6.6. Other Stability Testing Services
4.6.6.1. Other Stability Testing Services Market, 2018 - 2030 (USD Million)
4.7. Other Testing Services
4.7.1. Other Testing Services Market, 2018 - 2030 (USD Million)
CHAPTER 5. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: END USE BUSINESS ANALYSIS
5.1. End Use Market Share, 2024 & 2030
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.5. Biopharmaceutical Companies
5.5.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
CHAPTER 6. EUROPE PHARMACEUTICAL ANALYTICAL TESTING SERVICES IN CRO MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. Europe
6.4.1. Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. UK Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. France Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Regulatory Framework
6.4.5.3. Competitive Insights
6.4.5.4. Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Regulatory Framework
6.4.6.3. Competitive Insights
6.4.6.4. Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.7. Norway
6.4.7.1. Key Country Dynamics
6.4.7.2. Regulatory Framework
6.4.7.3. Competitive Insights
6.4.7.4. Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key Country Dynamics
6.4.8.2. Regulatory Framework
6.4.8.3. Competitive Insights
6.4.8.4. Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.9. Sweden
6.4.9.1. Key Country Dynamics
6.4.9.2. Regulatory Framework
6.4.9.3. Competitive Insights
6.4.9.4. Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.10. Poland
6.4.10.1. Key Country Dynamics
6.4.10.2. Regulatory Framework
6.4.10.3. Competitive Insights
6.4.10.4. Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.11. Switzerland
6.4.11.1. Key Country Dynamics
6.4.11.2. Regulatory Framework
6.4.11.3. Competitive Insights
6.4.11.4. Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.12. Austria
6.4.12.1. Key Country Dynamics
6.4.12.2. Regulatory Framework
6.4.12.3. Competitive Insights
6.4.12.4. Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.13. Czech Republic
6.4.13.1. Key Country Dynamics
6.4.13.2. Regulatory Framework
6.4.13.3. Competitive Insights
6.4.13.4. Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.14. Croatia
6.4.14.1. Key Country Dynamics
6.4.14.2. Regulatory Framework
6.4.14.3. Competitive Insights
6.4.14.4. Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.15. Slovenia
6.4.15.1. Key Country Dynamics
6.4.15.2. Regulatory Framework
6.4.15.3. Competitive Insights
6.4.15.4. Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.16. Greece
6.4.16.1. Key Country Dynamics
6.4.16.2. Regulatory Framework
6.4.16.3. Competitive Insights
6.4.16.4. Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates And Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. SGS Sociйtй Gйnйrale de Surveillance SA
7.5.1.1. Company Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Worldwide Clinical Trials
7.5.2.1. Company Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Sofpromed
7.5.3.1. Company Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. ClinChoice
7.5.4.1. Company Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Evotec
7.5.5.1. Company Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Eurofins Scientific
7.5.6.1. Company Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. KYMOS Group
7.5.7.1. Company Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. ViviaBiotech S.L.
7.5.8.1. Company Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. GalChimia
7.5.9.1. Company Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. TCI Laboratories
7.5.10.1. Company Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
7.5.11. Cotecna (NEOTRON SpA,)
7.5.11.1. Company Overview
7.5.11.2. Financial Performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic Initiatives
7.5.12. Tentamus
7.5.12.1. Company Overview
7.5.12.2. Financial Performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic Initiatives
7.5.13. Enzymlogic
7.5.13.1. Company Overview
7.5.13.2. Financial Performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic Initiatives
7.5.14. Pharmbiotest
7.5.14.1. Company Overview
7.5.14.2. Financial Performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic Initiatives
7.5.15. UNIFARM - Research Centre
7.5.15.1. Company Overview
7.5.15.2. Financial Performance
7.5.15.3. Product Benchmarking
7.5.15.4. Strategic Initiatives
7.5.16. ANAPHARM EUROPE, S.L.U
7.5.16.1. Company Overview
7.5.16.2. Financial Performance
7.5.16.3. Product Benchmarking
7.5.16.4. Strategic Initiatives
